Journal List > J Nutr Health > v.51(1) > 1081558

Kang, Lee, Son, and Park: Independent correlates of the toenail chromium level and the association between the chromium level and dyslipidemia

Abstract

Purpose

The number of patients with dyslipidemia have been increasing steadily over the past few decades in South Korea. The association between the chromium level and chronic disease has attracted considerable interest, but few studies have been conducted on the Korean population. The aim of this study was to identify the dietary and non-dietary correlates of the toenail chromium level, and evaluate the association between the toenail chromium level and dyslipidemia.

Methods

The baseline data of an ongoing prospective cohort study in Yeungnam area in South Korea were analyzed. A total of 500 participants aged 35 years or older who completed questionnaires on their demographics, lifestyle characteristics, and medical information were included. The toenail chromium level was analyzed by neutron activation analysis. The dietary intake was assessed using a validated 146-item semi-quantitative food frequency questionnaire. The blood lipid profiles were obtained from medical examinations conducted by the Korean National Health Insurance Service or medical institutions.

Results

Higher chromium levels were associated with the residential area (urban), higher education level, higher intakes of noodles and vegetables, and lower intake of fruits. Multiple logistic regression analysis showed that the toenail chromium levels were not associated significantly with the prevalence of dyslipidemia (odds ratio: 0.99, 95% confidence interval: 0.61 ~ 1.60).

Conclusion

This study is the first study in Korea to determine the independent correlates of the toenail chromium levels and the association between chromium exposure and dyslipidemia. These findings provide useful scientific evidence for the development of chromium intake guidelines for the Korean population.

Figures and Tables

Table 1

General characteristics of the study participants according to tertiles of toenail chromium levels

jnh-51-40-i001

Values are mean ± SE or n (%). T, tertiles; KRW, Korea Republic Won; METs, metabolic equivalents; LDL, low density lipoprotein; HDL, high density lipoprotein.

1) p values were derived from a chi-square test for categorical variables, and p for trends was derived from generalized linear regression analysis for continuous variables. 2) Body mass index was categorized into < 23 kg/m2 as underweight/normal, 23–24.9 kg/m2 as overweight, and ≥ 25 kg/m2 as obese based on BMI cut-offs for Asians by the World Health Organization.21 3) Physical activity level was calculated as a weekly METs-hour, and it was categorized into < 20 METs-h/week as low, 20–39 METs-h/week as moderate, and ≥ 40 METs-h/week as high. 4) Values are age and sex-adjusted mean ± SE.

Statistical significance is defined as *p < 0.05, **p < 0.01, ***p < 0.001, and NS stands for not significant.

Table 2

General characteristics of the study participants with and without dyslipidemia

jnh-51-40-i002

Values are mean ± SE or n (%). KRW, Korea Republic Won; METs, metabolic equivalents.

1) p values were derived from a chi-square test for categorical variables, and p for trends was derived from generalized linear regression analysis for continuous variables. 2) Body mass index was into < 23 kg/m2 as underweight/normal, 23–24.9 kg/m2 as overweight, and ≥ 25 kg/m2 as obese based on BMI cut-offs for Asians by the World Health Organization.21 3) Physical activity level was calculated as a weekly METs-hour, and it was categorized into < 20 METs-h/week as low, 20–39 METs-h/week as moderate, and ≥ 40 METs-h/week as high. Statistical significance level is defined as *p < 0.05, **p < 0.01, ***p < 0.001, and NS stands for not significant.

Table 3

Dietary and non-dietary correlates of toenail chromium levels

jnh-51-40-i003

Multivariable-adjusted findings including each of the variables in the table. Independent dietary predictors were identified using stepwise regression. KRW, Korea Republic Won; METs, metabolic equivalents.

1) Body mass index was into < 23 kg/m2 as underweight/normal, 23–24.9 kg/m2 as overweight, and ≥ 25 kg/m2 as obese based on BMI cut-offs for Asians by the World Health Organization.21 2) Physical activity level was calculated as a weekly METs-hour, and it was categorized into < 20 METs-h/week as low, 20–39 METs-h/week as moderate, and ≥ 40 METs-h/week as high.

Statistical significance level is defined as *p < 0.05, **p < 0.01, ***p < 0.001, and NS stands for not significant.

Table 4

Odds ratio and 95% confidence interval for dyslipidemia and its components according to toenail chromium levels

jnh-51-40-i004

T, tertiles; LDL, low density lipoprotein; HDL, high density lipoprotein. Model 1: unadjusted; Model 2: adjusted age, sex, and body mass index; Model 3: additionally adjusted for education level, smoking status, alcohol consumption, physical activity, monthly household income, residential area, and total energy intake; Model 4: additionally adjusted for family history of hypertension and diabetes.

Statistical significance level is defined as *p < 0.05, **p < 0.01, ***p < 0.001, and NS stands for not significant.

Notes

This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017R1A1A3A04069759). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3) [Internet]. Cheongju: Korea Centers for Disease Control and Prevention;2016. cited 2017 Dec 18. Available from: https://knhanes.cdc.go.kr/knhanes/sub04/sub04_03.do?classType=7.
2. Korean Society of Lipidology and Atherosclerosis. Dyslipidemia fact sheet in Korea [Internet]. Seoul: Korean Society of Lipidology and Atherosclerosis;2015. cited 2016 Mar 22. Available from: http://www.lipid.or.kr/bbs/index.html?code=fact_sheet&category=&gubun=&page=1&number=652&mode=view&keyfield=&key=.
3. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. National Heart, Lung, and Blood Institute. American College of Cardiology Foundation. American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110(2):227–239.
crossref
4. Tripathy JP, Thakur JS, Jeet G, Jain S. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr. 2017; 11:Suppl 1. S459–S465.
crossref
5. Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000; 284(3):311–318.
crossref
6. Guallar E, Jiménez FJ, van't Veer P, Bode P, Riemersma RA, Gómez-Aracena J, Kark JD, Arab L, Kok FJ, Martín-Moreno JM. EURAMIC-Heavy Metals and Myocardial Infraction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am J Epidemiol. 2005; 162(2):157–164.
crossref
7. Lombardo YB, Chicco AG. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem. 2006; 17(1):1–13.
crossref
8. Sirtori CR, Galli C, Anderson JW, Arnoldi A. Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis. 2009; 203(1):8–17.
crossref
9. Lewicki S, Zdanowski R, Krzyzowska M, Lewicka A, Debski B, Niemcewicz M, Goniewicz M. The role of Chromium III in the organism and its possible use in diabetes and obesity treatment. Ann Agric Environ Med. 2014; 21(2):331–335.
10. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998; 17(6):548–555.
crossref
11. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004; 27(11):2741–2751.
crossref
12. Stoecker BJ. Chromium absorption, safety, and toxicity. J Trace Elem Exp Med. 1999; 12(2):163–169.
crossref
13. Anderson RA, Polansky MM, Bryden NA, Patterson KY, Veillon C, Glinsmann WH. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983; 113(2):276–281.
crossref
14. Kozlovsky AS, Moser PB, Reiser S, Anderson RA. Effects of diets high in simple sugars on urinary chromium losses. Metabolism. 1986; 35(6):515–518.
crossref
15. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000; 106(4):453–458.
crossref
16. Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. J Clin Pharm Ther. 2014; 39(3):292–306.
crossref
17. Park K, Seo E. Association between toenail mercury and metabolic syndrome is modified by selenium. Nutrients. 2016; 8(7):E424.
crossref
18. Park K, Seo E. Toenail mercury and dyslipidemia: interaction with selenium. J Trace Elem Med Biol. 2017; 39:43–49.
crossref
19. Jang J, Morris JS, Park K. Toenail selenium levels and prevalence of dyslipidaemia among Korean adults. Br J Nutr. 2017; 118(6):473–480.
crossref
20. Willett W. Nutritional epidemiology. 3rd edition. New York (NY): Oxford University Press;2012.
21. World Health Organization Western Pacific Region. International Association for the Study of Obesity. International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment [Internet]. Sydney: Health Communications Australia Pty Limited;2000. cited 2017 February 27. Available from: http://iris.wpro.who.int/handle/10665.1/5379.
22. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, Heath GW, King AC, Kriska A, Leon AS, Marcus BH, Morris J, Paffenbarger RS, Patrick K, Pollock ML, Rippe JM, Sallis J, Wilmore JH. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995; 273(5):402–407.
crossref
23. Cheng TP, Morris JS, Koirtyohann SR, Spate VL, Baskett CK. The analysis of human nails for 24 elements via k0 and cyclic neutron activation analysis. Nucl Instrum Methods Phys Res A. 1994; 353(1-3):457–460.
crossref
24. Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, Willett WC, Hunter DJ. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev. 1993; 2(5):493–497.
25. Lee Y, Park K. Reproducibility and validity of a semiquantitative FFQ for trace elements. Br J Nutr. 2016; 116(5):864–873.
crossref
26. Smart GA, Sherlock JC. Chromium in foods and the diet. Food Addit Contam. 1985; 2(2):139–147.
crossref
27. Kumpulainen JT. Chromium content of foods and diets. Biol Trace Elem Res. 1992; 32(1-3):9–18.
crossref
28. Lendinez E, Lorenzo ML, Cabrera C, López MC. Chromium in basic foods of the Spanish diet: seafood, cereals, vegetables, olive oils and dairy products. Sci Total Environ. 2001; 278(1-3):183–189.
crossref
29. Bratakos MS, Lazos ES, Bratakos SM. Chromium content of selected Greek foods. Sci Total Environ. 2002; 290(1-3):47–58.
crossref
30. Bai J, Xun P, Morris S, Jacobs DR Jr, Liu K, He K. Chromium exposure and incidence of metabolic syndrome among American young adults over a 23-year follow-up: the CARDIA Trace Element Study. Sci Rep. 2015; 5:15606.
crossref
31. Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC, Hu FB. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care. 2004; 27(9):2211–2216.
crossref
32. Garcia E, Cabrera C, Lorenzo ML, Sánchez J, López MC. Daily dietary intake of chromium in southern Spain measured with duplicate diet sampling. Br J Nutr. 2001; 86(3):391–396.
crossref
33. Schuhmacher M, Domingo JL, Llobet JM, Corbella J. Chromium, copper, and zinc concentrations in edible vegetables grown in Tarragona Province, Spain. Bull Environ Contam Toxicol. 1993; 50(4):514–521.
crossref
34. Zayed A, Lytle CM, Qian JH, Terry N. Chromium accumulation, translocation and chemical speciation in vegetable crops. Planta. 1998; 206(2):293–299.
crossref
35. Lima KV, Lima RP, Gonçalves MC, Faintuch J, Morais LC, Asciutti LS, Costa MJ. High frequency of serum chromium deficiency and association of chromium with triglyceride and cholesterol concentrations in patients awaiting bariatric surgery. Obes Surg. 2014; 24(5):771–776.
crossref
36. Krzysik M, Grajeta H, Prescha A, Weber R. Effect of cellulose, pectin and chromium(III) on lipid and carbohydrate metabolism in rats. J Trace Elem Med Biol. 2011; 25(2):97–102.
crossref
37. He K. Trace elements in nails as biomarkers in clinical research. Eur J Clin Invest. 2011; 41(1):98–102.
crossref
38. Ministry of Health and Welfare (KR). The Korean Nutrition Society. Dietary reference intakes for Koreans 2015 [Internet]. Sejong: Ministry of Health and Welfare;2016. cited 2017 Apr 29. Available from: http://www.kns.or.kr/FileRoom/FileRoom_view.asp?mode=mod&restring=%252FFileRoom%252FFileRoom.asp%253Fxsearch%253D0%253D%253Dxrow%253D10%253D%253DBoardID%253DKdr%253D%253Dpage%253D1&idx=79&page=1&BoardID=Kdr&xsearch=1&cn_search=.
TOOLS
Similar articles